Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Potassium chloride provides potassium ions essential for maintaining intracellular tonicity, transmembrane potential, and nerve impulse transmission. Dextrose 5% provides a source of calories and may improve serum osmolality. Sodium chloride 0.9% supplies sodium and chloride ions to maintain extracellular fluid volume and electrolyte balance.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous infusion: 10-20 mEq/hour, not to exceed 40 mEq/hour or 200 mEq/day. Maximum concentration: 80 mEq/L via peripheral line, 200 mEq/L via central line. Rate dependent on serum potassium and clinical condition.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Not applicable as potassium is an endogenous electrolyte; distribution and elimination follow first-order kinetics with a rapid redistribution phase (t1/2 α ~15 min) and a slower terminal phase (t1/2 β ~6-8 h) reflecting equilibration with total body stores.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Renal (approximately 90% as potassium ion); minimal biliary/fecal elimination (<5% collectively).
Category C
Category A/B
Electrolyte
Electrolyte